Recordati SpA - Company Profile
Powered by 
All the data and insights you need on Recordati SpA in one report.
$295
- Save hours of research time and resources with
our up-to-date Recordati SpA Strategy Report
- Understand Recordati SpA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Recordati SpA patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| PL3796888T3 | Grant | NEW SALT OF CYSTEAMINE FOR THE PREPARATION OF HIGHLY RESPIRABLE PARTICLES | A61K2300/00; A61K31/145; A61K31/728; A61K47/36; A61K9/0075; A61K9/1617; A61K9/1652; A61K9/167; A61K9/1694; A61P11/00; A61P11/12 | May 09, 2022 |
| ES2908829T3 | Grant | Nueva sal de cisteamina para la preparación de partículas altamente respirables | A61K2300/00; A61K31/145; A61K31/728; A61K47/36; A61K9/0075; A61K9/1617; A61K9/1652; A61K9/167; A61K9/1694; A61P11/00; A61P11/12 | May 04, 2022 |
| LT3796888T | Grant | NEW SALT OF CYSTEAMINE FOR THE PREPARATION OF HIGHLY RESPIRABLE PARTICLES | A61K2300/00; A61K31/145; A61K31/728; A61K47/36; A61K9/0075; A61K9/1617; A61K9/1652; A61K9/167; A61K9/1694; A61P11/00; A61P11/12 | April 11, 2022 |
| EP3972580A1 | Application | BEHANDLUNG VON HYPERAMMONÄMIE BEI PATIENTEN MIT NIERENINSUFFIZIENZ | A61K31/197; A61K31/198; A61P13/12; A61P3/12 | March 30, 2022 |
| DK3796888T3 | Application | NYT SALT AF CYSTEAMIN TIL FREMSTILLING AF HØJT INHALERBARE PARTIKLER | A61K2300/00; A61K31/145; A61K31/728; A61K47/36; A61K9/0075; A61K9/1617; A61K9/1652; A61K9/167; A61K9/1694; A61P11/00; A61P11/12 | March 14, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer